Skip to content
Screener

Sotera Health SHC EPS (Diluted)

EPS (Diluted) at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
-$0.03-103%
Fortive logo
FortiveFTV
$0.51+4.1%
ECV
EcovystECVT
$0.07+40.0%
Perspective Therapeutics logo
Perspective TherapeuticsCATX
-$0.250.0%
Labcorp Holdings logo
Labcorp HoldingsLH
$3.64+28.2%
Waste Management logo
Waste ManagementWM
$1.95+8.3%

Other financials

Income statement

See full
Revenue$321.4M+9.2%
Gross profit$178.0M+6.8%
Operating income$87.1M-16.2%
Net income$53.6M+574%

Balance sheet

See full
Cash & equivalents$356.7M+7.3%
Total debt$2.3B-3.5%
Total equity$665.6M+30.2%
Total assets$3.3B+2.8%

Cash flow

See full
Operating cash flow$88.5M+54.1%
CapEx$46.4M+48.7%
Free cash flow$42.0M+60.6%

Valuation

See full
Market cap$5.13B+71.8%
Enterprise value$7.04B+41.6%
P/E31.4×-92.9×
P/S4.2×+1.6×

Profitability

See full
Gross margin55%-0.6pp
Operating margin27%+0.7pp
Net margin13.4%+11.3pp
FCF margin9.3%

Returns & leverage

See full
Return on equity27.8%+22.6pp
Debt / equity3.4×-1.2×
Current ratio2.8×+0.3×

Where this comes from

Reported directly by Sotera Health in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Sotera Health’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:04 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q3 2026
Accession
0001822479-26-000047
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Foreign currency translation(18,591)82,217(36,222)101,777
Comprehensive income$36,128$89,127$46,615$94,665
Earnings (Loss) per share:
Basic$0.19$0.03$0.28$(0.02)
Diluted0.190.030.28(0.02)
Weighted average number of shares outstanding:
Basic285,773283,933285,333283,747
Diluted288,148285,756287,915283,747

Item 1. Financial Statements.

FAQ

What is Sotera Health's EPS (diluted)?
Sotera Health (SHC) reported EPS (diluted) of $0.19 in Q2 2026.
How has Sotera Health's EPS (diluted) changed year-over-year?
Sotera Health's EPS (diluted) increased by 533.3% year-over-year, from $0.03 to $0.19.
What is the long-term trend for Sotera Health's EPS (diluted)?
Over 4 years (2021 to 2025), Sotera Health's EPS (diluted) has grown at a -9.9% compound annual growth rate (CAGR), from $0.41 to $0.27.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Sotera Health's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude